Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia

Abstract

Cell therapy can be considered as a new alternative to the treatment of post-traumatic syringomyelia, achieving reduction of syrinx and clinical improvements in individual patients.